IP Library Patent Application 13566646
Patent Application
App. No. 13/566,646

DALBAVANCIN COMPOSITIONS FOR TREATMENT OF BACTERIAL INFECTIONS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/566,646
Abstract

The invention provides methods for drying dalbavancin. The method includes providing wet dalbavancin that includes dalbavancin, water, and a solvent. The wet dalbavancin is dried at at a temperature of about 30° C. or less, at a vacuum pressure of about 50 mbar or less, until the water level of the wet dalbavancin is less than about 20% (w/w). Water is then added to the dalbavancin and the resulting wet dalbavancin is dried at least once more at a temperature of about 30° C. or less, at a vacuum pressure of about 50 mbar or less, until the solvent level of the dalbavancin is less than about 3.0% (w/w).

Claims (24)

1 . A method for drying dalbavancin, comprising the steps of:

providing wet dalbavancin comprising dalbavancin, water, and a solvent;

drying the wet dalbavancin at a temperature of about 30° C. or less, at a vacuum pressure of about 50 mbar or less, until the water level of the wet dalbavancin is less than about 20% (w/w);

adding water to the dalbavancin; and

drying the wet dalbavancin at least once more at a temperature of about 30° C. or less, at a vacuum pressure of about 50 mbar or less, until the solvent level of the dalbavancin is less than about 3.0% (w/w).

2 . The method of claim 1 , wherein the steps of adding water and drying the wet dalbavancin at a temperature of about 30° C. or less, at a vacuum pressure of about 50 mbar or less are repeated until the solvent level is less than about 3.0% (w/w).

3 . The method of claim 1 , wherein the steps of adding water and drying the wet dalbavancin at a temperature of about 30° C. or less, at a vacuum pressure of about 50 mbar or less are repeated until the solvent level is less than about 2.5% (w/w).

4 . The method of claim 1 , wherein the steps of adding water and drying the wet dalbavancin at a temperature of about 30° C. or less, at a vacuum pressure of about 50 mbar or less are repeated until the solvent level is less than about 2.0% (w/w).

5 . The method of claim 1 , wherein the steps of adding water and drying the wet dalbavancin at a temperature of about 30° C. or less, at a vacuum pressure of about 50 mbar or less are repeated until the solvent level is less than about 1.5% (w/w).

6 . The method of claim 1 , wherein the steps of adding water and drying the wet dalbavancin at a temperature of about 30° C. or less, at a vacuum pressure of about 50 mbar or less are repeated until the solvent level is less than about 1.0% (w/w).

7 . The method of claim 1 , wherein the steps of adding water and drying the wet dalbavancin at a temperature of about 30° C. or less, at a vacuum pressure of about 50 mbar or less are repeated until the solvent level is less than about 0.5% (w/w).

8 . The method of claim 1 , wherein the solvent is acetone.

9 . The method of claim 1 , wherein the solvent is selected from the group consisting of ethanol, methanol, propanol, butanol, ether, methylene chloride, tetrahydrofuran, chloroform, 1,4-dioxane, and trichloroethylene.

10 . The method of claim 1 , wherein the wet dalbavancin is dried at a temperature of about 28° C. or less.

11 . The method of claim 1 , wherein the wet dalbavancin is dried at a temperature of about 26° C. or less.

12 . The method of claim 1 , wherein the wet dalbavancin is dried at a temperature of about 24° C. or less.

13 . The method of claim 1 , wherein the wet dalbavancin is dried at a vacuum pressure of about 40 mbar or less.

14 . The method of claim 1 , wherein the wet dalbavancin is dried at a vacuum pressure of about 30 mbar or less.

15 . The method of claim 1 , wherein the wet dalbavancin further comprises MAG and wherein, after drying, the MAG is present in less than about 3.0 percent HPLC distribution.

16 . The method of claim 1 , wherein the wet dalbavancin further comprises MAG and wherein, after drying, the MAG is present in less than about 2.5 percent HPLC distribution.

17 . The method of claim 1 , wherein the wet dalbavancin further comprises MAG and wherein, after drying, the MAG is present in less than about 2.0 percent HPLC distribution.

18 . The method of claim 1 , wherein the wet dalbavancin further comprises MAG and wherein, after drying, the MAG is present in less than about 1.5 percent HPLC distribution.

19 . The method of claim 1 , wherein the wet dalbavancin further comprises MAG and wherein, after drying, the MAG is present in less than about 1.0 percent HPLC distribution.

20 . The method of claim 1 , wherein the wet dalbavancin further comprises MAG and wherein, after drying, the MAG is present in less than about 0.5 percent HPLC distribution.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Dec 17, 2014
From: PDL BIOPHARMA, INC.
To: VICURON PHARMACEUTICALS INC.
Reel/Frame 034527/0843 →
SECURITY AGREEMENT Recorded Oct 31, 2013
From: VICURON PHARMACEUTICALS INC.
To: PDL BIOPHARMA, INC.
Reel/Frame 031529/0353 →
ASSIGNEE CHANGE OF ADDRESS Recorded Oct 18, 2013
From: VICURON PHARMACEUTICALS INC.
To: VICURON PHARMACEUTIALS INC.
Reel/Frame 031438/0688 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 18, 2013
From: STOGNIEW, MARTIN
To: VICURON PHARMACEUTICALS INC.
Reel/Frame 031438/0870 →